Paeds Vivas · growth-development-and-behaviour
Toilet training and elimination behaviour — branching viva
Viva on toilet-training readiness, enuresis phenotype and non-punitive elimination management.
On this page & tools
Target exams
Stem
You are in clinic with a 7-year-old and parents. They report frequent night wetting, stained underwear and large hard stools. They want to punish wet nights and ask for a tablet before camp. [1] [11]
Examiner: How do you open this consultation? [1]
Strong answer: Without blame. Name that wetting and soiling are common and usually involuntary. Stop punishment first, then assess phenotype, constipation and red flags. [1] [13]
Examiner: Classify the likely continence phenotype. [2] [3]
Strong answer: Primary nocturnal enuresis — if no significant daytime LUTS this is MNE by ICCS language — plus retentive encopresis with constipation and overflow. Age thresholds are met (enuresis ≥5, encopresis ≥4). [2] [3] [11]
Examiner: What is the enuresis triad? [13]
Strong answer: Nocturnal polyuria, reduced nocturnal bladder capacity or overactivity, and impaired arousal from sleep. Children load differently on these factors. [2] [13]
Examiner: Why treat the bowel before or with the bedwetting plan? [9]
Strong answer: Rectal loading drives overflow soiling and can compress the bladder (bowel–bladder axis). Clearing constipation often improves urinary symptoms and treatment adherence. [9] [11]
Examiner: Alarm versus desmopressin — when each? [4] [5] [6]
Strong answer: Alarm for durable cure when family is ready. Desmopressin for short-term dryness (camp/sleepover) or when alarm is unsuitable, failed or refused. Desmopressin usually works only while taken. [4] [5] [6]
Examiner: Safety counselling if desmopressin is used for camp? [6] [14]
Strong answer: Evening free-water restriction; stop during vomiting or diarrhoea; warn about headache, vomiting and hyponatraemic seizures; verify product information for dose. [6] [14]
Examiner: Name three red flags that change the pathway today. [1] [2]
Strong answer: Secondary onset with polyuria/polydipsia; continuous daytime wetting; neurological or spinal signs; coercive toileting needing safeguarding. [1] [2]
Examiner: Close with disposition. [1] [4] [9]
Strong answer: Non-punitive bowel programme now; alarm pathway for cure; camp desmopressin if appropriate; review; escalate to continence/urology/GI/mental health if red flags, resistance or high psychosocial risk. [1] [4] [9]
References
- [1]Fritz G, Rockney R, et al. Practice parameter for the assessment and treatment of children and adolescents with enuresis J Am Acad Child Adolesc Psychiatry, 2004.PMID 15564822
- [2]Neveus T, Eggert P, Evans J, et al. Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International Children's Continence Society J Urol, 2010.PMID 20006865
- [3]Neveus T, von Gontard A, Hoebeke P, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society J Urol, 2006.PMID 16753432
- [4]Nunes VD, O'Flynn N, Evans J, Sawyer L Management of bedwetting in children and young people: summary of NICE guidance BMJ, 2010.PMID 20980375
- [5]Caldwell PH, Codarini M, Stewart F, Hahn D, Sureshkumar P Alarm interventions for nocturnal enuresis in children Cochrane Database Syst Rev, 2020.PMID 32364251
- [6]Hahn D, et al. Desmopressin for nocturnal enuresis in children Cochrane Database Syst Rev, 2025.PMID 40728007
- [9]Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN J Pediatr Gastroenterol Nutr, 2014.PMID 24345831
- [11]Loening-Baucke V Functional fecal retention with encopresis in childhood J Pediatr Gastroenterol Nutr, 2004.PMID 14676600
- [13]Butler RJ Childhood nocturnal enuresis: developing a conceptual framework Clin Psychol Rev, 2004.PMID 15533278
- [14]Chin X, et al. Desmopressin therapy in children and adults: pharmacological considerations and clinical implications Eur J Clin Pharmacol, 2022.PMID 35199198